New nasal spray offers hope for depression that Won't respond to pills
NCT ID NCT07053345
Summary
This study is testing whether a nasal spray containing esketamine can help reduce symptoms of depression in Korean patients whose depression hasn't improved with at least two standard antidepressant medications. About 47 participants will use the nasal spray for 4 weeks while researchers track changes in their depression scores. The main goal is to see if this treatment provides meaningful relief for people with treatment-resistant depression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSIVE DISORDER, TREATMENT-RESISTANT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asan Medical Center
RECRUITINGSeoul, 05505, South Korea
-
Cha Ilsan Medical Center
RECRUITINGGoyang Si Gyeonggi Do, 10414, South Korea
-
Kangbuk Samsung Hospital
RECRUITINGSeoul, 03181, South Korea
-
Kyung Hee University Hospital
RECRUITINGSeoul, 130 050, South Korea
-
Samsung Medical Center
RECRUITINGSeoul, 06351, South Korea
-
Wonkwang University Hospital
RECRUITINGIksan, 570 711, South Korea
Conditions
Explore the condition pages connected to this study.